Magnetic resonance imaging agents for calcification
OwnerKumar Ranjan Bhushaninventor
Life of this patent
Estimating the term…
Abstract
The present invention discloses magnetic resonance compatible contrast agents for water-poor structures, such as bone and tissue calcification. In particular, the present invention discloses bisphosphonate-based magnetic resonance imaging contrast agents specific for hydroxyapatite, the calcium salt most commonly associated with malignant calcification.
Claims21
A contrast agent represented in general formula [I], and pharmaceutically acceptable salts, hydrates and solvents thereof:
- wherein
- BP is a bisphosphonate;
- is a linker;
- and
- is a metal chelate selected independently from:
A contrast agent represented in general formula [II], and pharmaceutically acceptable salts, hydrates and solvents thereof:
- wherein
- BP is a bisphosphonate;
- is a linker;
- and
- M is Y, In, Gd, Eu, or a lanthanide.
A contrast agent having a formula selected from the group consisting of:
- wherein
- BP is a bisphosphonate;
- is a linker;
- and
- M is Y, In, Gd, Eu, or a lanthanide.
A method of making a contrast agent, said method comprising:
- (a) providing an organic chelating ligand, wherein said organic chelating ligand selected from the group consisting of:
- wherein
- R is t-butyl ester, ester or hydrogen;
- and
- R1 is
- (b) reacting said organic chelating ligand with a linker, wherein said linker having a primary amine and a carboxylic moiety at opposing ends;
- (c) treating said carboxylic moiety with oxalyl chloride under conditions capable of forming an acid chloride at said carboxylic moiety;
- (d) reacting said acid chloride in one pot with trialkyl phosphite and dialkyl phosphite to form a alkylester protected bisphosphonate;
- (e) deprotecting one or more carboxylic acid ester of said organic chelating ligand to yield one or more carboxylic acid functionality;
- (f) chelating a metal ion to result in a metal chelate, wherein said linker separate said metal chelate and said alkylester protected bisphosphonate;
- and
- (g) deprotecting one or more bisphosphonate ester of said alkylester protected bisphosphonate, wherein deprotection results in said contrast agent.
A method of making a contrast agent, said method comprising:
- (a) providing an organic chelating ligand, wherein said organic chelating ligand selected from the group consisting of:
- wherein
- R is t-butyl ester, ester or hydrogen;
- and
- R1 is
- (b) reacting said organic chelating ligand with a linker, wherein said linker having a primary amine and a carboxylic moiety at opposing ends;
- (c) deprotecting one or more carboxylic acid ester of said organic chelating ligand to yield one or more carboxylic acid functionality;
- (d) chelating a metal ion to result in a metal chelate, wherein said linker on said metal chelate having said carboxylic moiety;
- and
- (e) reacting an amino bisphosphonate with said carboxylic moiety of said metal chelate under a condition capable of forming amide bond to results in said contrast agent.
A method of making a contrast agent, said method comprising:
- (a) providing an organic chelating ligand, wherein said organic chelating ligand selected from the group consisting of:
- wherein
- R is t-butyl ester, ester or hydrogen;
- and
- R1 is
- (b) reacting an amino bisphosphonate with said organic chelating ligand under a condition capable of forming amide bond between said amino bisphosphonate and said organic chelating ligand;
- (c) deprotecting one or more carboxylic acid ester of said organic chelating ligand to yield one or more carboxylic acid functionality;
- and
- (d) chelating a metal ion to said one or more carboxylic acid ester of said organic chelating ligand to result in said contrast agent.
Dependencies are inferred from the claim text.